Skip to main content
. Author manuscript; available in PMC: 2024 Feb 8.
Published in final edited form as: Cephalalgia. 2023 Jul;43(7):3331024231187162. doi: 10.1177/03331024231187162

Table 2.

Percentage of respondents who reported individual headache-associated symptoms.

% respondents reporting All (n=6662) Migraine (44.3%) Prob Mig (22.4%) TTH (5.1%) TAC (1.2%) Other (0.4%) PTH (11.1%) NDPH (10.3%) Undefined (4.8%)
Light sensitivity 64.1 81.6 45.6 19.9 86.6 13.8 71.3 61.2 23.1
Sound sensitivity 49.2 67.9 25.7 5.9 70.7 6.9 56.3 49.7 12.2
Nausea 48.2 70.9 23.2 0.0 59.8 6.9 49.5 45.9 10.0
Dizziness* 47.7 54.4 36.7 18.5 74.4 17.2 57.9 54.8 25.2
Lightheaded 39.8 46.4 28.7 13.2 67.1 13.8 48.3 46.8 18.7
Room spinning 18.7 21.8 13.4 6.2 26.8 3.4 22.2 24.7 5.9
Balance problem 18.7 19.8 12.7 5.3 32.3 10.3 29.9 23.7 10.6
Trouble thinking 37.7 44.1 25.4 14.7 56.1 10.3 51.7 42.2 14.3
Blurry vision 30.0 33.8 22.1 12.9 43.9 3.5 37.9 35.6 18.1
Vomiting 23.2 38.2 11.4 0.0 19.5 6.9 15.4 14.1 5.3
Smell sensitivity 16.6 24.5 7.0 1.8 30.5 6.9 15.1 17.4 3.1
Neck pain 16.1 19.8 8.8 4.7 25.6 10.3 24.0 20.4 5.9
Ear ringing 14.8 16.3 9.5 6.5 26.8 6.9 20.8 21.1 5.3
Double vision 6.4 6.9 4.4 3.5 11.0 0.0 10.0 7.8 1.9

HA = Headache, sx = symptom, GI = gastrointestinal,

*

Dizziness = proportion of individuals who reported any of the following: lightheadedness, room spinning, balance problems. Overall, 2.3% had missing GI symptom data (nausea, vomiting), 2.1% had missing visual symptom data (blurry vision, double vision), and 2.1% were missing all other symptoms.